Cargando…

Pharmacogenetics may Influence Tacrolimus Daily Dose, but not Urinary Tubular Damage Markers in the Long-Term Period after Renal Transplantation

BACKGROUND: The primary goal of this study was to evaluate the influence of cytochrome P450 (CYP) 3A5 (6986A>G) and ABCB1 (3435C>T) polymorphisms on tacrolimus (TAC) dosage regimen and exposure. Second, we evaluated the influence of TAC dosage regimen and the tested polymorphisms on renal oxid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanović, Nikola Z., Cvetković, Tatjana P., Veličković-Radovanović, Radmila M., Jevtović-Stoimenov, Tatjana M., Vlahović, Predrag M., Stojanović, Ivana R., Pavlović, Dušica D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Medical Biochemists of Serbia 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922361/ https://www.ncbi.nlm.nih.gov/pubmed/28356851 http://dx.doi.org/10.1515/jomb-2015-0001

Ejemplares similares

Effect of the Interrelation between CYP3A5 Genotype, Concentration/Dose Ratio and Intrapatient Variability of Tacrolimus on Kidney Graft Function: Monte Carlo Simulation Approach
por: Stefanović, Nikola, et al.
Publicado: (2021)

Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol – Differences or Similarities?
por: Cvetković, Tatjana, et al.
Publicado: (2015)

How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients
por: Dimitrijevic, Zorica M., et al.
Publicado: (2012)

Current Biochemical Monitoring and Risk Management of Immunosuppressive Therapy after Transplantation
por: Catić-Đorđević, Aleksandra, et al.
Publicado: (2017)

Sodium nitroprusside and peroxynitrite effect on hepatic DNases: an in vitro and in vivo study
por: Kocic, Gordana, et al.
Publicado: (2004)

Clinical Importance of Potential Genetic Determinants Affecting Propofol Pharmacokinetics and Pharmacodynamics
por: Budic, Ivana, et al.
Publicado: (2022)

The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma
por: Jovanović, Nikola, et al.
Publicado: (2019)

Immunosuppressive Medication Adherence in Kidney Transplant Patients
por: Lalić, Jelena, et al.
Publicado: (2014)

The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children
por: Pavlovic, Dimitrije, et al.
Publicado: (2020)

Utility of salivary mycophenolic acid concentration monitoring: Modeling and Monte Carlo validation approach
por: Catić‐Đorđević, Aleksandra, et al.
Publicado: (2022)

Boerhaave syndrome - case report: Síndrome de Boerhaave - relato de caso
por: Dinic, Biljana Radovanovic, et al.
Publicado: (2016)

L-Arginine Intake Effect on Adenine Nucleotide Metabolism in Rat Parenchymal and Reproductive Tissues
por: Kocic, G., et al.
Publicado: (2012)

Circulating Ribonucleic Acids and Metabolic Stress Parameters May Reflect Progression of Autoimmune or Inflammatory Conditions in Juvenile Type 1 Diabetes
por: Kocic, Gordana, et al.
Publicado: (2011)

Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
por: Cvetkovic, Tatjana, et al.
Publicado: (2022)

Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation
por: Milenković, Jelena, et al.
Publicado: (2016)

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
por: Moes, D. J. A. R, et al.
Publicado: (2015)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
por: Brunet, Mercè, et al.
Publicado: (2022)

Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction
por: Andrejic, Olivera M., et al.
Publicado: (2019)

Oxidant and Antioxidant Status in Experimental Rat Testis after Testicular Torsion/Detorsion
por: Cvetkovic, Tatjana, et al.
Publicado: (2015)

Can Salivary Biomarkers Be Used as Predictors of Dental Caries in Young Adolescents?
por: Stojković, Branislava, et al.
Publicado: (2020)

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
por: Yu, Meng, et al.
Publicado: (2018)

Association of Plasma Renalase and Left Ventricle Mass Index in Heart Failure Patients Stratified to the Category of the Ejection Fraction: A Pilot Study
por: Stojanovic, Dijana, et al.
Publicado: (2019)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients
por: Madsen, Mads Juul, et al.
Publicado: (2017)

Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation
por: Bzeizi, Khalid Ibrahim, et al.
Publicado: (2021)

Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study
por: Marković, Danica, et al.
Publicado: (2018)

Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure
por: Vucic, Rada M., et al.
Publicado: (2023)

Pharmacogenetic distinction of the Croatian population from the European average
por: Celinšćak, Željka, et al.
Publicado: (2022)

Lack of Association of Tumor Necrosis Factor-α G–308A and Transforming Growth Factor-β1 C–509T Polymorphisms in Patients with Deep Neck Space Infections
por: Jevtović-Stoimenov, T, et al.
Publicado: (2013)

The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
por: Pavlović, Milan, et al.
Publicado: (2017)

Hydrocortisone/norepinephrine/tacrolimus: Acute tubular necrosis: case report
Publicado: (2021)

Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations
por: van Gelder, Teun, et al.
Publicado: (2020)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Agmatine protection against chlorpromazine-induced forebrain cortex injury in rats
por: Dejanovic, Bratislav, et al.
Publicado: (2016)

The Timing of Infarction Pain in Patients with Acute Myocardial Infarction after Previous Revascularization
por: Mitrovic, Predrag M., et al.
Publicado: (2008)

Factors affecting the long-term response to tacrolimus in renal transplant patients: Pharmacokinetic and pharmacogenetic approach
por: Katsakiori, Paraskevi F., et al.
Publicado: (2010)

Tuberculosis and COVID-19 co-infection in Serbia: Pandemic challenge in a low-burden country
por: Adzic-Vukicevic, Tatjana, et al.
Publicado: (2022)

Conversion From Twice-Daily Tacrolimus to Once-Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial
por: Bunnapradist, S, et al.
Publicado: (2013)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
por: Kim, Jong Man, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_283dpk7v0o9sitiong9e580sed